| Literature DB >> 28304115 |
Robert A DeSimone1, Joseph Schwartz2, Jennifer Schneiderman3.
Abstract
In adults, extracorporeal photopheresis (ECP) is widely utilized for a variety of indications, most commonly cutaneous T-cell lymphoma, acute or chronic graft-versus-host disease (GVHD), solid organ transplant rejection, and other autoimmune and T-cell-mediated disorders. In pediatric patients, the majority of case series and reports have focused on its use in the management of acute and chronic GVHD. Currently utilized ECP technologies were designed for adult patients and there are several challenges in adapting these technologies for use in children. In our review, we focus on practical considerations and procedural modifications for ECP use in pediatric patients, with special attention to patient safety.Entities:
Keywords: extracorporeal photopheresis (ECP); graft-versus-host disease (GVHD); pediatrics; therapeutic apheresis
Mesh:
Year: 2017 PMID: 28304115 DOI: 10.1002/jca.21534
Source DB: PubMed Journal: J Clin Apher ISSN: 0733-2459 Impact factor: 2.821